STOCK TITAN

Conmed Corp - CNMD STOCK NEWS

Welcome to our dedicated page for Conmed news (Ticker: CNMD), a resource for investors and traders seeking the latest updates and insights on Conmed stock.

Conmed Corporation (CNMD) delivers innovative medical technologies that enhance surgical outcomes and patient care worldwide. This dedicated news hub provides investors and healthcare professionals with timely updates on corporate developments, financial performance, and product advancements shaping the medical device sector.

Access authoritative information on CNMD's latest earnings reports, regulatory milestones, and strategic partnerships. Our curated collection includes press releases detailing new product launches in orthopedics, general surgery, and patient monitoring systems, along with updates on global market expansion initiatives.

Stay informed about critical developments through verified announcements directly from Conmed Corporation and third-party analysis. This resource enables stakeholders to track the company's progress in advancing minimally invasive surgical techniques and improving clinical workflows across healthcare institutions.

Bookmark this page for streamlined access to CNMD's evolving role in medical technology innovation. Regularly updated content supports informed analysis of the company's market position and long-term growth trajectory within the competitive healthcare solutions landscape.

Rhea-AI Summary
CONMED promoted Patrick Beyer to Chief Operating Officer, expanding his responsibilities to lead commercial businesses, operations, distribution, regulatory affairs, and customer excellence. Mr. Beyer's promotion reflects his track record of driving above-market growth and expanding the company's presence in key markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.58%
Tags
none
-
Rhea-AI Summary
CONMED reported strong financial results for the first quarter of 2024, with sales reaching $312.3 million, a 5.7% increase year-over-year. Domestic revenue saw a 7.2% growth, while international revenue increased by 3.8%. Diluted net earnings per share were $0.63 (GAAP) compared to $0.06 in Q1 2023, with adjusted diluted net earnings per share at $0.79, a 19.7% increase. The company expects reported revenue for the full year to be between $1.330 billion and $1.355 billion, with adjusted diluted net earnings per share projected in the range of $4.25 to $4.35.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.58%
Tags
-
Rhea-AI Summary
CONMED (CNMD) will release its first-quarter 2024 financial results on April 24, 2024, followed by a conference call to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
Rhea-AI Summary
CONMED Corporation (CNMD) declares a quarterly cash dividend of $0.20 per share, payable on April 5, 2024, to shareholders of record as of March 15, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
dividends
-
Rhea-AI Summary
CONMED Corporation (CNMD) reported a 30.4% increase in sales for the fourth quarter of 2023 compared to the previous year, with domestic revenue up by 33.3%. International revenue also saw a significant increase. The company's full-year 2023 sales increased by 19.1% year over year, with both domestic and international revenues showing strong growth. Adjusted diluted net earnings per share for the fourth quarter of 2023 increased by 152.4% compared to the same period in 2022. The company expects continued growth in 2024, with a projected year-over-year revenue increase of 8% to 10% and adjusted diluted net earnings per share growth of 25% to 28%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.38%
Tags
-
Rhea-AI Summary
CONMED Corporation (CNMD) to report Q4 2023 financial results on January 31, 2024. Conference call scheduled for 4:30 p.m. ET on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.7%
Tags
Rhea-AI Summary
CONMED Corporation (CNMD) to Present at J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
conferences
-
Rhea-AI Summary
CONMED Corporation (CNMD) declares a quarterly cash dividend of $0.20 per share, payable on January 5, 2024, to shareholders of record as of December 18, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.09%
Tags
dividends
-
Rhea-AI Summary
CONMED Corporation (NYSE: CNMD) to Participate in Fireside Chat at Piper Sandler Healthcare Conference on November 28, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.53%
Tags
conferences
Rhea-AI Summary
CONMED Corporation (NYSE: CNMD) will participate in fireside chats at two investor conferences in November. The first conference is the Stifel Healthcare Conference in New York, NY on November 14, 2023, where Curt R. Hartman and Eric Staves will be the speakers. The second conference is the Jefferies London Healthcare Conference in London, UK on November 15, 2023, where Todd W. Garner and Pat J. Beyer will be the speakers. The fireside chats will be accessible through the Company's website and will be available for replay.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
conferences
Conmed Corp

NYSE:CNMD

CNMD Rankings

CNMD Stock Data

1.57B
30.76M
0.58%
117.9%
7.45%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
LARGO